Loading... Please wait... Loading... Please wait...
| Reporting Date | Major Shareholder Name | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| 05/15/2024 | 22NW, LP | 5.37 M | $15.40 M | 0.00% | 20.81% |
| 04/18/2024 | LVW ADVISORS, LLC | 642,039 | $1.84 M | -0.16% | 2.49% |
| 05/15/2024 | NANTAHALA CAPITAL MANAGEMENT, LLC | 511,073 | $1.47 M | 0.00% | 1.98% |
| 05/15/2024 | MORGAN STANLEY | 399,219 | $1.15 M | 0.00% | 1.55% |
| 05/17/2024 | IKARIAN CAPITAL, LLC | 157,862 | $453,064 | 0.00% | 0.61% |
| 05/10/2024 | VANGUARD GROUP INC | 153,472 | $440,465 | 0.31% | 0.60% |
| 05/07/2024 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 25,253 | $72,476 | 100.00% | 0.10% |
| 05/13/2024 | GEODE CAPITAL MANAGEMENT, LLC | 22,777 | $65,430 | 100.00% | 0.09% |
| 05/15/2024 | BOOTHBAY FUND MANAGEMENT, LLC | 18,978 | $54,467 | 0.00% | 0.07% |
| 05/15/2024 | TOWER RESEARCH CAPITAL LLC (TRC) | 5,138 | $14,746 | -43.55% | 0.02% |
| 05/10/2024 | BLACKROCK INC. | 4,049 | $11,620 | -2.32% | 0.02% |
| 05/13/2024 | UBS GROUP AG | 144 | $413 | 100.00% | 0.00% |
| 05/10/2024 | WELLS FARGO & COMPANY/MN | 62 | $178 | 1.64% | 0.00% |
| 05/10/2024 | JPMORGAN CHASE & CO | 9 | $26 | 100.00% | 0.00% |
| 05/15/2024 | BANK OF AMERICA CORP /DE/ | 0 | $0 | -100.00% | 0.00% |
| 05/09/2024 | LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 0 | $0 | -100.00% | 0.00% |
| 05/15/2024 | ADAR1 CAPITAL MANAGEMENT, LLC | 0 | $0 | -100.00% | 0.00% |
A. During the previous two years, 20 institutional investors and hedge funds held shares of Anebulo Pharmaceuticals, Inc.. The most heavily invested institutionals were:
22NW, LP: 5.37 M
LVW Advisors, LLC: 642,039
Nantahala Capital Management, LLC: 511,073
MORGAN STANLEY: 399,219
Ikarian Capital, LLC: 157,862
VANGUARD GROUP INC: 153,472
A. 28.33% of Anebulo Pharmaceuticals, Inc. stock is owned by institutional investors.
A. Institutional investors have bought a total of 7.32 M shares in the last 24 months. This purchase volume represents approximately $19.98 M in transactions.
